ArticleBMC genomics2026
Proteomic dynamics of bull sperm during post-testicular maturation.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Mammalian sperm maturation during epididymal transit is driven by sequential interactions with the epididymal environment allowing the acquisition, loss and modification of sperm protein content. We report a comparative proteomic profile of testicular, caput and cauda epididymal spermatozoa using shotgun proteomics. Analysis rendered 2,305 proteins in testicular sperm (TestSperm), 2,554 in caput epididymal sperm (CaputSperm) and 2,038 in cauda epididymal sperm (CaudaSperm), including 702, 483 and 314 unique proteins, respectively. Gene Ontology (GO) enrichment analysis of total proteomes and unique proteins from each population allowed us to map biological processes (BP) to spermatozoa with sequential degrees of maturation. TestSperm was mostly enriched in processes related to post-transcriptional regulation, that may be reminiscent mechanisms to regulate spermatogenesis and sperm differentiation. GO enrichment analysis of BP in CaputSperm proteome identified a significant enrichment of integrin-mediated and non-classical endocytic pathways may be aiding in sperm-epididymosome interaction and vesicle fusion events. CaudaSperm was significantly enriched in BP related to specific sperm functions (motility, fertilization) and associated to oxidative phosphorylation (OXPHOS) reflecting that sperm maturation involves a transition from a glycolytic metabolism (prevalent in testicular sperm) to being more dependent on OXPHOS, as ejaculated sperm. An in silico analysis further revealed how proteins are associated with specific sperm functions/events (motility, acrosome reaction/capacitation, fertilization and embryo development). Most proteins related to these functions seem to be present since the testicular phase and maintained through maturation. Interestingly, ubiquitin–proteasome system (UPS) catabolic processes appear to be significantly enriched in the conserved epididymal sperm proteome across species. Finally, we identified several sperm histones and variants and, together with an in silico analysis, we also identified histone modifying enzymes in each sperm population. Contrarily to common believe, our results suggest that histone replacement by protamines is not completed in the testis and continues through epididymal transit. Detection of histone modifying enzymes in CaputSperm suggests that histone PTMs might be more prevalent in caput epididymis where they may play a role in achieving the necessary balance between histone eviction and retainment. Our study emphasizes the pivotal role that sperm proteomic remodeling plays in post-testicular maturation, in the sequential acquisition of competence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.